Pharmaceuticals
GoodRx Doesn't Look So Good
Here's what it's going to take to turn the charts positive.
Amid the Risky Market, Regeneron Offers Glimmer of Hope
I see a rare attractive technical setup in this pharma name.
Can Bristol-Myers Squibb Finally Make an Upside Breakout?
Maybe third time's the charm.
I'm Replacing My Acquired 2022 Stock Pick of the Year With Its Acquirer
Collegium Pharmaceutical should benefit greatly from its pending purchase of my stock pick for this year, BioDelivery Sciences International.
Options Play of the Week: We've Got You 'Covered' With This Biopharma
I like the setup here with potential catalysts on the horizon and lucrative as well as liquid options available against the equity.
We're Changing Our Strategy on AstraZeneca
Even today's earnings beat is not 'moving the needle' enough.
A Subscriber Wants to Know If Aurinia Pharmaceuticals' Charts Have Improved
Prices look like they can bounce further to the upside in the short-run but the longer-term picture is problematic.
CVS Health Reports Q4 Results: Here's How I'm Trading the Shares
Following earnings Wednesday morning, there's going to be some profit taking.
Let's See If CVS's Charts Look Healthy Ahead of Earnings
Here's what traders should do now.
Pfizer's Charts Need a Shot in the Arm
Let's take a look at the charts and indicators.